Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: April 29, 2026
CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 30, 2026
Real world experience with omission of therapeutic lymph node dissection in clinical stage III malignant melanoma treated with checkpoint or kinase inhibition systemic therapy.
Journal: Surgical oncology insight
Published: April 10, 2025
Plasmablastic lymphoma achieving sustained remission with antiretroviral therapy alone.
Journal: European journal of haematology
Published: July 20, 2019
Showing 1-4 of 4
Last Updated: 09/26/2026